Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 251 followers

Latest posts

Last updated 2 days ago

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 25, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation...

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Date of authorisation: 30/06/2009, Revision: 25, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 24, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation...

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of authorisation: 21/04/2013, Revision: 13, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of...

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation...

Human medicines European public assessment report (EPAR): Zoely, nomegestrol,estradiol, Date of authorisation: 26/07/2011, Revision: 25, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Zoely, nomegestrol,estradiol, Date of authorisation...

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation...

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation...